Your Navigation:PCAR > Abstract
Search pcar
Pharmaceutical Care and Research: 2018; 18(2):153-156
DOI: 10.5428/pcar20180220
Pharmaceutical consultation of a patient with severe fever combined with thrombocytopenia syndrome and multiple organ dysfunction
1. WANG ChuanZhu(a
2. WANG Qi(a
3. WANG Xi(a )
Welcome to PCAR! You are the number 374 reader of this article!
Please cite this article as:
WANG ChuanZhu,WANG Qi,WANG Xi,. Pharmaceutical consultation of a patient with severe fever combined with thrombocytopenia syndrome and multiple organ dysfunction[J]. Pharmaceutical Care and Research / yao xue fu wu yu yan jiu. 2018; 18(2): 153-156.
1. Ministry of Health,the People’s Republic of China.Guidelines for the prevention and treatment of severe fever with thrombocytopenia syndrome(2010 vesrion)[J].Chin J Clin Infect Dis,2014,4(4): 193-194.In Chinese.
2. Chinese Expert Group on Extensive Drug Resistance.Translated by WANG MingGui.Laboratory diagnosis,clinical management and infection control of the infections caused by extensively drug-resistant Gram-negative bacilli: a Chinese consensus statement[J].Chin J Infect Chemother,2017,17(1): 82-92.In Chinese with English title.
3. Lee L S,Kinzig-Schippers M,Nafziger A N,et al.Comparison of 30-min and 3-h infusion regimens for imipenem/cilastatin and for meropenem evaluated by monte carlo simulation[J].Diagn Microbiol Infect Dis,2010,68(3):251-258.
4. Expert Committee of Clinical Application of Bicyclic Alcohol Tablets.Expert advice of clinical application of bicyclic alcohol tablets[J].Chin J Exp Clin Infect Dis,2014,8(6): 875-879.In Chinese.
5. Asthma Group of Respiratory Disease Branch,Chinese Medical Association.The diagnosis and treatment guidelines for cough(2015 version)[J].Chin J Tuberc Respir Dis,2016,39(5):323-354.In Chinese.
6. LIU XianJun,FU Na.Analysis of 109 reports of adverse drug reactions caused by cefoperazone sodium and sulbactam sodium for injection[J].Chin Pharmacovigil,2014,11(6):355-357.In Chinese with English abstract.
7. Craig W A.Pharmacokinetic/pharmacodynamic parameters:rationale for antibacterial dosing of mice and men[J].Clin Infect Dis,1998,26(1):1-12.
8. Lodise T P Jr,Lomaestro B,Drusano G L.Piperacillin-tazobactam for Pseudomonas aeruginosa infection:clinical implications of an extended-infusion dosing strategy[J].Clin Infect Dis,2007,44(3):357-363.
9. Lü Yang,YAN Zhao,WANG DongHao,et al.Treatment study of hospital acquired pneumonia by optimizing dosing regimen of piperaeillin/tazobactam:prolonged vs regular infusion[J].Chin Crit Care Med,2013,25(8):479-483.In Chinese with English abstract.
10. Gilbert D N.Hot disease:The Sanford guide to antimicrobial therapy[M].46th ed.Translated by FAN HongWei.Beijing:Peking Union Medical College Press,2017:120.In Chinese.
11. LING Lan,LIN JiangTao.Anti-inflammatories of macrolide antibiotics in respiratory diseases[J].J China-Japan Friendship Hosp,2009,23(4):247-249,253.In Chinese.
12. ZHANG XiaoDong,PENG Cheng,XIAO YongHong.Effect of macrolides and anti-Pseudomonas aeruginosa antibiotics on eradicating Pseudomonas aeruginosa biofilms[J].Med J West China,2005,17(6):548-550.In Chinese with English abstract.
13. Microecology Branch of the Chinese Society of Preventive Medicine.The consensus on the clinical application of microecological regulator of digestive tract in China(2016 version)[J].Chin J Microecol,2016,28(6):621-631.In Chinese.
《药学服务与研究》杂志社 All Rights Reserved 网站备案号:鲁B2-20061008
·地址:上海市杨浦区长海路168号18号楼东三楼 邮政编码:200433
·联系电话(传真):86-21-65519829, 021-31162330